Page 52 - THE COVID-19 CHRONICLES OF MALAYSIA Embracing Ripples: Coursing Forward
P. 52
Reporting of AEFI
For Optimal Protection, Mix & Match
22 January 2022: Serious
21 January 2022: Mix and Match Please Recipients of the full dose of Sinovac vaccine AEFI for a Booster Dose is 23,427 (AEFI)
(CoronaVac®) are strongly encouraged to take either AstraZeneca vaccine Rare NPRA AEFI Reporting
(Covishield®/Vaxzevria®) or Pfizer-BioNTech vaccine (Comirnaty®) as booster doses System shows that there
for optimal protection. § are 51 cases with serious
side effect out of
10,192,887 booster doses Booster dose
that were administrated, 10,192,887 1st&2nd dose 51,530,767
equivalent to 0.005 reports
per 1,000 doses. § 51 (Serious cases)
984 (AEFI)
Channels to Report AEFI Vaccine recipients could report AEFI via ConSERF on the
NPRA website while healthcare workers could report through the NPRA website or
Pharmacy Information System (PhIS) for MOH facilities. §
Source: KJ Twitter §
Malaysia-Singapore VTL Resumed VTL between the 2 countries will be resumed today,
with the ticket quota limited to 50% capacity of the bus and flight. §
Source: NPRA Portal §
Source: New China TV Youtube §
Source: PhIS Portal §
22
Source: CNA News §